The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ATAI Life Sciences N.V’s current trading price is -0.23% away from its 52-week high, while its distance from the 52-week low is 326.21%. The stock’s price range for this period has been between $1.03 and $4.40 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.96 million for the day, a number notably higher than the average daily volume of 5.47 million over the last three months.
At present, ATAI Life Sciences N.V (ATAI) has a stock price of $4.39. In the previous session, the stock saw a rise, peaking at $16.0 after an opening price of $4.39. The day’s lowest price was $7.0, and it closed at $3.97.
The market performance of ATAI Life Sciences N.V’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $4.40 on 08/21/25, while the lowest value for the same duration was $1.03 on 10/11/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ATAI Life Sciences N.V (ATAI) has experienced a quarterly rise of 129.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 940.94M and boasts a workforce of 54 employees.
ATAI Life Sciences N.V: What Analysts Are Saying
As of right now, 8 analysts are rating ATAI Life Sciences N.V as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.42, with a change in price of +2.92. Similarly, ATAI Life Sciences N.V recorded 4,155,394 in trading volume during the last 100 days, posting a change of +198.64%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ATAI stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.02.
ATAI Stock Stochastic Average
As of today, ATAI Life Sciences N.V’s raw stochastic average for the last 50 days stands at 94.51%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 90.55%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 75.46% and 71.01%, respectively.
ATAI Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 235.11%.However, over the last six months, we can see a weaker performance of 115.20%. Over the last 30 days, the price of ATAI has fallen by 13.14%. And in the last five days, it has surged by 9.48%.
